LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with newly diagnosed gliomas.

Trial Details

NCT ID
NCT04699773
Phase
NA
Sponsor
University of Maryland, Baltimore
Status
RECRUITING
Cancer Type
Glioblastoma (GBM) Brain Cancer
Interventions
  • LITT
  • Hypofractionated Radiation Therapy
Locations (sample)
  • Baltimore, Maryland, United States|39.29038,-76.61219
  • Baltimore, Maryland, United States|39.29038,-76.61219
  • Bel Air, Maryland, United States|39.53594,-76.34829
  • Columbia, Maryland, United States|39.24038,-76.83942
  • Glen Burnie, Maryland, United States|39.16261,-76.62469

Key Eligibility Criteria

  • Patients with radiographic evidence of suggestive of a primary high-grade glioma
  • Brain MRI with contrast demonstrates an enhancing mass within 60 days prior to registration. Patient must be deemed a candidate for LITT from MRI b…
  • History and physical including neurological exam within 30 days prior to registration
  • Karnofsky performance status ≥50% within 30 days prior to registration

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Glioblastoma (GBM) Brain Cancer Trials on Trialify →